A man with a gene that made him more susceptible to Alzheimer’s managed to keep the disease at bay thanks to natural immunity. The Colombian man was predicted to have dementia in his 40s, but he died at the age of 74
The first drug proven to slow Alzheimer’s is on sale, but most U.S. patients will not be able to receive the treatment for several months. Experts say some reasons behind the slow debut for Leqembi, from Japanese drugmaker Eisai, are minimal insurance